Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
Krzysztof Jamroziak, MD, PhD
Advertisement
Articles by Krzysztof Jamroziak, MD, PhD
Advertisement
Latest Updated Articles
MRD Recurrence Shown to Precede Biochemical Relapse in Multiple MyelomaPublished: June 26th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Looking Beyond Genomics to Advance Precision Medicine in Cancer Care
2
Progastrin-Releasing Peptide Levels Correlate With OS and PFS in LS-SCLC
3
Two-Fraction SBRT Shows Acceptable Toxicity in Prostate Cancer Population
4
What Direction Should Marginal Zone Lymphoma Research Be Heading?
5
